Weitgasser R, Schnöll F, Pretsch I, Gruber U, Sailer S
II. Medizinischen Abteilung, Landeskrankenanstalten Salzburg.
Acta Med Austriaca. 1998;25(2):61-4.
In intensive insulin therapy frequent measurements of blood glucose are necessary for daily insulin adjustments. The aim of our study was to determine acceptance of frequent blood glucose measurements and its relation to quality of glycemic control over a period of 5 years. We report on 57 unselected patients with type 1 diabetes mellitus, who were at least half a year under intensive insulin therapy when entering the study. Mean age was 34 +/- 9, diabetes duration 18 +/- 8 years. The number of daily blood glucose measurements, HbA1c, body mass index, daily insulin dose, routine laboratory values, number of severe hypoglycemic reactions and frequency of retinopathy, nephropathy and neuropathy were determined for year 1 and 5. We found an increase in daily blood glucose measurements from 2.5 to 4.5 per day (year 1 resp. year 5). The frequency of blood glucose measurements at the begin of our study respectively after 5 years was: < or = 2.0/day in 51% vs. 12%, > 2.0 but < 4.0/day in 20% vs. 21% and > or = 4.0/day in 29% vs. 67% of patients. HbA1c decreased from 7.3 +/- 1.2 to 6.4 +/- 1.1% after 5 years (p < 0.001). A comparison of subgroups of patients showed that frequency of blood glucose measurement is not the only cause for this improvement, but adequate education of diabetic patients seems to be most important. Retinopathy and neuropathy increased despite better diabetic control, 2 patients developed microalbuminuria, all other data determined at study entry remained unchanged after 5 years. We conclude that frequent daily blood glucose measurements were accepted by the majority of our patients over a long period of time. Mean blood glucose determined by HbA1c improved under intensive insulin therapy. In our study group with low HbA1c values at baseline this effect was only partly related to the frequency of daily blood glucose measurements.
在强化胰岛素治疗中,为了每日调整胰岛素剂量,需要频繁测量血糖。我们研究的目的是确定在5年期间频繁测量血糖的接受程度及其与血糖控制质量的关系。我们报告了57例未经挑选的1型糖尿病患者,他们在进入研究时至少已接受强化胰岛素治疗半年。平均年龄为34±9岁,糖尿病病程为18±8年。测定了第1年和第5年的每日血糖测量次数、糖化血红蛋白(HbA1c)、体重指数、每日胰岛素剂量、常规实验室值、严重低血糖反应次数以及视网膜病变、肾病和神经病变的发生率。我们发现每日血糖测量次数从每天2.5次增加到了4.5次(第1年和第5年)。在我们研究开始时以及5年后,血糖测量频率分别为:≤2.0次/天的患者占51%对12%,>2.0但<4.0次/天的患者占20%对21%,≥4.0次/天的患者占29%对67%。5年后,HbA1c从7.3±1.2%降至6.4±1.1%(p<0.001)。对患者亚组的比较表明,血糖测量频率不是这种改善的唯一原因,但对糖尿病患者进行充分的教育似乎最为重要。尽管糖尿病控制有所改善,但视网膜病变和神经病变仍有增加,2例患者出现微量白蛋白尿,5年后在研究开始时测定的所有其他数据均未改变。我们得出结论,大多数患者在很长一段时间内都接受了每日频繁测量血糖。在强化胰岛素治疗下,通过HbA1c测定的平均血糖得到了改善。在我们基线HbA1c值较低的研究组中,这种效果仅部分与每日血糖测量频率有关。